Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N-Acetyltransferase 2, glutathione S-transferase gene polymorphisms and susceptibility to hepatocellular carcinoma in an Algerian population. | Xenobiotica | 2022 | 35138223 | PubTator, text mining | PubMed |
| [Association between isoniazid induced hepatotoxicity and host N-acetyltransferase 2 polymorphisms]. | Zhonghua Jie He He Hu Xi Za Zhi | 2022 | 35135095 | PubTator, text mining | PubMed |
| Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure. | Clin Infect Dis | 2022 | 35134861 | PubTator, text mining | PubMed |
| Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis. | Mol Carcinog | 2022 | 35133049 | PubTator, text mining | PubMed |
| PSD3 downregulation confers protection against fatty liver disease. | Nat Metab | 2022 | 35102341 | PubTator, text mining | PubMed |
| Identification of sex-specific genetic associations in response to opioid analgesics in a White, non-Hispanic cohort from Southeast Minnesota. | Pharmacogenomics J | 2022 | 35102242 | PubTator, text mining | PubMed |
| A limited form of granulomatosis with polyangiitis in an ulcerative colitis patient receiving sulfasalazine. | Saudi Med J | 2022 | 35022291 | PubTator, text mining | PubMed |
| Development of population pharmacokinetics model of isoniazid in Indonesian patients with tuberculosis. | Int J Infect Dis | 2022 | 35017103 | PubTator, text mining | PubMed |
| Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways. | Cancers (Basel) | 2022 | 35008399 | PubTator, text mining | PubMed |
| Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma. | Int Immunopharmacol | 2022 | 35008004 | PubTator, text mining | PubMed |
| Dill Shows Potential for Herb-Drug Interactions via Up-Regulation of CYP1A2, CYP2C19, SULT1A1, NAT2 and ABCB1 in Caco-2 Cells. | Pak J Biol Sci | 2022 | 35001576 | PubTator, text mining | PubMed |
| Impact of Pineapple Juice on Expression of CYP3A4, NAT2, SULT1A1 and OATP1B1 mRNA in HepG2 Cells. | Pak J Biol Sci | 2022 | 35001571 | PubTator, text mining | PubMed |
| The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity. | Transl Oncol | 2022 | 34990909 | PubTator, text mining | PubMed |
| Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population. | Hered Cancer Clin Pract | 2022 | 34983599 | PubTator, text mining | PubMed |
| Clinical development of metabolic inhibitors for oncology. | J Clin Invest | 2022 | 34981784 | PubTator, text mining | PubMed |
| A genome-wide scan to locate regions associated with familial vesicoureteral reflux. | Exp Ther Med | 2022 | 34976134 | PubTator, text mining | PubMed |
| Pharmacogenomics of Antihypertensive Drugs in Brazil: Recent Progress and Clinical Implications. | Endocr Metab Immune Disord Drug Targets | 2022 | 34951375 | PubTator, text mining | PubMed |
| Association of NAT-2 gene polymorphisms toward lung cancer susceptibility and prognosis in North Indian patients treated with platinum-based chemotherapy. | Pharmacogenomics | 2022 | 34911343 | PubTator, text mining | PubMed |
| Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe. | Mol Diagn Ther | 2022 | 34905151 | PubTator, text mining | PubMed |
| Pharmacogenetics of the Late-Onset Efavirenz Neurotoxicity Syndrome (LENS). | Clin Infect Dis | 2022 | 34882770 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=27